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Abstract
Background:  During early steps of embryonic development the hindbrain undergoes a
regionalization process along the anterior-posterior (AP) axis that leads to a metameric
organization in a series of rhombomeres (r). Refinement of the AP identities within the hindbrain
requires the establishment of local signaling centers, which emit signals that pattern territories in
their vicinity. Previous results demonstrated that the transcription factor vHnf1 confers caudal
identity to the hindbrain inducing Krox20 in r5 and MafB/Kreisler in r5 and r6, through FGF signaling
[1].
Results: We show that in the chick hindbrain, Fgf3 is transcriptionally activated as early as 30 min
after mvHnf1 electroporation, suggesting that it is a direct target of this transcription factor. We
also analyzed the expression profiles of FGF activity readouts, such as MKP3 and Pea3, and showed
that both are expressed within the hindbrain at early stages of embryonic development. In addition,
MKP3 is induced upon overexpression of mFgf3 or mvHnf1 in the hindbrain, confirming vHnf1 is
upstream FGF signaling. Finally, we addressed the question of which of the FGF-responding
intracellular pathways were active and involved in the regulation of Krox20  and  MafB in the
hindbrain. While Ras-ERK1/2 activity is necessary for MKP3, Krox20 and MafB induction, PI3K-Akt
is not involved in that process.
Conclusion: Based on these observations we propose that vHnf1 acts directly through FGF3, and
promotes caudal hindbrain identity by activating MafB and Krox20 via the Ras-ERK1/2 intracellular
pathway.
Background
The hindbrain is the most posterior vesicle of the embry-
onic brain. During early steps of neural development, the
hindbrain is transiently organized in segments along the
anterior-posterior (AP) axis, which are called rhom-
bomeres (r). This transient segmental organization is nec-
essary for the correct specification of the different
neuronal subtypes, the location of the cranial nerve exit
points, and the migration streams of the neural crest cells
from the dorsal hindbrain towards the branchial arches.
Rhombomeres display a specific combinatory of gene
expression that confers molecular identity to the rhombo-
meric territories, and they are compartment-like units
with cell lineage restriction (for reviews see [2,3]).
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Refinement of the AP identities within the hindbrain
requires the establishment of local signaling centers,
which emit signals that pattern territories in their vicinity.
Two signaling centers which emit FGF and WNT signals
are located within the hindbrain: the Isthmic Organizer
(IsO), at the level of the Midbrain-Hindbrain Boundary
(MHB) (for review see [3,4]), and the 'r4-FGF source' [5].
FGFs emitted from the central and caudal hindbrain have
been demonstrated to be crucial for hindbrain specifica-
tion. In zebrafish, fgf3 and fgf8 from r4 have redundant
functions in patterning the hindbrain [6,7], whereas in
chick and mouse Fgf3 dynamically expressed in the r4-r6
region is needed for the specification of the caudal hind-
brain [1,8-10]. Gain-of-function experiments in zebrafish
suggested that FGFs from the hindbrain cooperate with
the transcription factor vHnf1 in the specification of the
caudal hindbrain [11,12]. This cooperation occurs early
during neurulation and leads to the induction of two
genes involved in rhombomeric specification, Krox20 for
r5 and MafB for r5 and r6. Results in chick suggest that
vHnf1 operates upstream of FGF signaling in this regula-
tion: vHnf1 not only cooperates with Fgf3 in the induction
of Krox20 and MafB , but also regulates Fgf3 expression
[1]. Analyses of the Krox20 and MafB regulatory regions in
mice have shown that they contain functional vHNF1-
binding sites, suggesting that vHnf1  can control these
genes in a direct manner as well [13,14].
One of the questions that have challenged developmental
biologists in the last years is how FGF signaling can gener-
ate such a different array of responses in the several devel-
opmental events in which is involved. It is known that
these very diverse outcomes are context dependent, with
FGF signaling acting in a cellular environment defined by
previous and current signaling activities [15]. One of the
most accepted hypotheses considers that the activation
and tuning of different intracellular pathways down-
stream FGF signaling can generate part of this variability.
Among those, the FGF-downstream intracellular cascades
Ras-ERK1/2 and PI3K-Akt are those that have mostly been
related to embryonic patterning events. Different and in
some cases contradictory models have been proposed for
the involvement of Ras-ERK1/2 and PI3K-Akt pathways in
different tissues and systems [16-20]. In addition, the FGF
signaling system is tightly regulated by a series of modula-
tors, which exert their functions at different levels of the
pathway, from the FGFR to specific components of the
different intracellular pathways (reviewed in [21]). The
expression of these genes is induced by FGF activity itself
and regional and temporal variation in their levels of
expression is though to tune FGF signaling to the appro-
priate levels for each particular event. The term 'synexpres-
sion group' has been adopted to designate sets of genes
that share complex spatio-temporal expression patterns
and have a functional relationship [22]. Synexpression
groups form expression cassettes that can be found at dif-
ferent times and locations during development. The FGF
factors, such as Fgf8  and  Fgf4, and FGFRs (FGFR1-4),
together with negative modulators of FGF signaling
(MKP3, SPRY2, Sef and Spred ), the positive modulator
FLRT3 and transcription factors such as the members of
the Ets-type family Pea3, Erm and Er81 have been desig-
nated as the 'FGF synexpression group' [21,23]. The aim
of the present work was to dissect the FGF-intracellular
cascade involved in caudal hindbrain patterning. Further
to our previous observations on the regulation of Fgf3 in
the chick hindbrain, we provide evidence suggesting that
Fgf3 is a direct transcriptional target of vHnf1. We provide
a detailed spatial and temporal map of expression of key
components of the FGF signaling system such as MKP3,
Pea3 and of Ras-ERK1/2 and PI3K-Akt activity in the hind-
brain at early stages of embryonic development. We also
analyze the functional activity of the intracellular path-
ways downstream FGF signaling using specific chemical
inhibitors. The results show that MKP3 expression colo-
calizes with activated ERK1/2 and it is sensitive to inhibi-
tion of Ras-ERK1/2. This pathway mediates the functions
of FGF3 signaling in caudal hindbrain specification regu-
lating the expression of Krox20  and  MafB  , without
involvement of the PI3K-Akt pathway. Altogether these
data provide new insights in the repertoire of FGF path-
way genes associated to hindbrain development and on
the role of FGF signaling in caudal hindbrain specifica-
tion.
Results
Fgf3 is rapidly induced after vHnf1 overexpression
Previous work indicated that Fgf3  was downstream of
vHnf1 in the induction of caudal rhombomeric markers
such as Krox20 and MafB . vHnf1 operates in a specific
time-window and is not able to induce Fgf3,  MafB  or
Krox20  at late stages of hindbrain patterning [1]. One
important question was to know whether Fgf3 was a direct
downstream target of vHnf1. To address this issue we stud-
ied the time course of Fgf3 induction after mvHnf1 overex-
pression. We designed a semiquantitative RT-PCR
approach to determine the kinetics of Fgf3  induction.
Embryos of 3-4ss (HH8) were electroporated with
mvHnf1 and incubated at 38°C during different time peri-
ods (15 min, 30 min, 1 h, 3 h, 6 h). After incubation, the
hindbrain tissue was isolated and processed for RT-PCR
amplification. 15 min after electroporation, a band of 600
bp corresponding to mvHnf1 expression at both 25 and 27
cycles was amplified (Fig. 1Aa, B), indicating the amount
of ectopic mvHnf1 already transcribed in the embryo. The
number of cycles used, 25 and 27, was to show that we
were not under saturation conditions. At the same time
point, a weaker 450 bp band corresponding to the endog-
enous  cFgf3  expression was amplified by RT-PCR (Fig.
1Aa, B). To avoid biased results and to be able to compareBMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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between different time points, the ratio of intensity cFgf3/
mvHnf1 was always used to analyze the data. As incuba-
tion time increased (30 min and 1 h), the intensity of the
cFgf3 band was progressively stronger in respect to the
mvHnf1  band (Fig. 1Ab-c, B). From 1 h onwards, the
intensity of the cFgf3 band was relatively similar for all
time points, suggesting that either the reaction reached
saturation or vHnf1 was not able to induce cFgf3 transcrip-
tion anymore (Fig. 1Ad, B). Thus, as early as 30 min after
electroporation the endogenous expression of Fgf3 was
increased and by 1 h a plateau was reached (Fig. 1B). Con-
trol experiments were performed with a form of vHnf1
containing the Q136E substitution in the POU-specific
domain that completely abolishes DNA-binding [1,24].
The construct was overexpressed and embryos were incu-
bated at 38°C during 6 h (Fig. 1Ae). The cFgf3 relative lev-
els of expression were much higher in experimental
samples than in the control (compare Fig. 1Ad and 1Ae,
Fig. 1C for quantification).
These results suggest that vHnf1 positively regulates Fgf3
in the chick hindbrain. The RT-PCR semiquantitative
analysis shows that Fgf3 is rapidly induced after vHnf1
overexpression, suggesting a direct transcriptional regula-
tion. Although regulatory analysis of the mouse Fgf3 gene
revealed a DNA region driving Fgf3  expression to the
hindbrain, this enhancer region does not fully recapitu-
late the dynamics of Fgf3 expression within the hindbrain
and it did not bring much light into the transcription fac-
tor binding candidates [25].
Akt and ERK1/2 pathways are active in the caudal 
hindbrain
The FGF signals exert their function by activating different
intracellular pathways. Although five intracellular path-
ways are known to be downstream of FGF signaling,
mainly Ras-ERK1/2 and, to a lesser extent, PI3K-Akt have
been related to embryonic processes in different tissues
and models [16-19]. Given that FGF signaling controls
Krox20 and MafB expression [1,10], our next question was
to study which of these intracellular networks were acti-
vated downstream Fgf3 in the caudal hindbrain.
For this purpose, the activated forms of FGF effectors
within the hindbrain at early stages of embryonic devel-
opment were analyzed. Caudal hindbrain tissue from
HH8-HH9 stage embryos was isolated and western blot
analysis was performed to detect the Akt and ERK1/2
phosphorylated forms (pAkt and pERK1/2). When anti-
bodies against both the total and the phosphorylated
forms of Akt were used in protein extracts of isolated hind-
brains, a 60 kD band corresponding to Akt was obtained
in both cases (Fig. 2a). This result suggests that the PI3K-
Akt pathway is active at these stages of hindbrain pattern-
ing. Western blot analysis detecting either the total or the
phosphorylated forms of ERK1/2 revealed that Ras-ERK1/
2 pathway was also active during this period (Fig. 2a). As
positive controls for ERK1/2 and Akt activation, protein
extracts of whole embryos were used (Fig. 2a).
Next, we wanted to analyze the spatial distribution of the
FGF activities. With this in mind, we performed whole-
mount immunodetection of pERK1/2 with embryos at
HH8-HH10 stages. As shown in Fig. 2b-h, pERK1/2 was
detected in embryonic territories within or close to FGF
reported sources such as: the anterior neural ridge (ANR),
the mid-hindbrain boundary (MHB), the precardiac mes-
oderm (pm), the primitive strike (ps), the caudal neural
plate, and the presomitic and intermediate mesoderm
Fgf3 is rapidly induced after mvHnf1 overexpression Figure 1
Fgf3 is rapidly induced after mvHnf1 overexpression. 
Embryos were electroporated with mvHnf1-GFP construct 
and incubated during different time periods. After the 
desired incubation period the hindbrain tissue was processed 
for total RNA extraction and one-step RT-PCR amplification 
for cFgf3 and mvHnf1. (A) Amplified bands corresponding to 
cFgf3 and mvHnf1 checked after 25 and 27 cycles. Samples 
correspond to 15 min (a), 30 min (b), 1 h (c) and 6 h (d) after 
mvHnf1 overexpression, or 6 h after mvHnf1-Q136E overex-
pression (e). Amplification of GAPDH was run in parallel to 
normalize sample values (f). (B) The ratio of intensity 
between the cFgf3 and the mvHnf1 band at each time point 
was calculated and plotted in the graphic, in order to analyze 
the relative level of cFgf3 expression. A quantification pro-
gram was used to calculate the intensity of each band and it 
was expressed in percentage of volume of the band (cFgf3/
mvHnf1, see M&M). (C) Comparison of cFgf3/mvHnf1 ratio 
after mvHnf1 or mvHnf1-Q136E overexpression.BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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(Fig. 2b-e; [20]). Between HH8 and HH10 Fgf3  is
expressed in a domain corresponding to r4 and r5 (Fig. 3;
[1,26]). Coincident with this expression domain, the Ras-
ERK1/2 pathway was also active in the hindbrain at 4ss
(HH8) (Fig. 2b). By HH9 pERK1/2 persisted in the caudal
hindbrain and it was extended to the rostral hindbrain,
the MHB and the caudal midbrain (Fig. 2b, d). Flat-
mounted hindbrains in Fig. 2e showed that pERK1/2 was
excluded from the ventral part of the tube, with the excep-
tion of the caudal hindbrain, where it was localized all
along the dorsoventral axis. At HH10, Ras-ERK1/2 activity
was still maintained in the hindbrain (Fig. 2f-h). The
strongest activity was localized in the MHB (Fig. 2f-h).
Unfortunately, it was not possible to analyze the pAkt spa-
tial distribution since available antibodies did not work in
whole-mount immunostainings.
Expression of the readouts of FGF activity in the caudal 
hindbrain
To further investigate the FGF signaling system during
hindbrain patterning, we checked for the expression of
genes of the synexpression group that could act as read-
outs of FGF activity, to study whether they recapitulate the
Fgf3 expression profile and, therefore, can be used as local
readouts of the FGF3 activity in the caudal hindbrain.
Phosphorylated forms of Akt and ERK1/2 are present in the caudal hindbrain Figure 2
Phosphorylated forms of Akt and ERK1/2 are present in the caudal hindbrain. (a) Western Blot analysis of protein 
extracts of whole embryos (left column) and isolated caudal hindbrain (right column). Phosphorylated (activated) forms of both 
Akt and ERK1/2 were present in protein extracts from the caudal hindbrain. Total forms of Akt and ERK1/2 were used as load-
ing controls. pERK1/2 immunodetection is shown in red (b, d-e, h-k) or in green fluorescence in (f). In situ hybridization with 
vHnf1-Hoxb1 (c) and vHnf1 (g) to position the caudal hindbrain. (i-k) Control experiments to show the specificity of pErk stain-
ing: embryos incubated with DMSO (i) or with SU5402 (j), and assayed for pErk (note that specific pErk staining in the MHB 
and in the caudal hindbrain disappears upon SU5402 treatment); (k) embryos treated as in (i) but without pErk-Ab incubation, 
as negative control. Whole-mount embryos (b-d, f-g, i-k), or flat-mounted hindbrains (e, h) at indicated stages. ANR, anterior 
neural ridge; cHB, caudal hindbrain; FB, forebrain; HB, hindbrain; im, intermediate mesoderm; MHB, midbrain-hindbrain bound-
ary; pm, precardiac mesoderm; ps: primitive strike; psm, presomitic mesoderm. Anterior is at the top.BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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Fgf3 is the most strongly expressed Fgf during hindbrain
patterning displaying a dynamic pattern of expression
[26]. At 2ss (HH7+), Fgf3 transcripts were already present
in the prospective hindbrain (Fig. 3a). At HH8 and HH9
Fgf3 expression was maintained in the caudal hindbrain
occupying a domain corresponding to the presumptive
r4-r5 territory (Fig. 3b, g). Transverse sections show that at
this stage, Fgf3 expression was restricted to the ventral part
of the hindbrain (Fig. 3e, arrowheads), with the exception
of the floor plate, and to the hindbrain-underlying meso-
derm (Fig. 3e, see arrow). At HH10 Fgf3 was still expressed
in r4 and r5 (Fig. 3d, h) and in the endoderm that gives
rise to the pharyngeal pouches (Fig. 3d, f, arrow).
MKP3 (MAPK Phosphatase 3) is a phosphatase belonging
to the Ras-ERK1/2 pathway that is commonly regulated by
FGF signaling [16,17,27,28]. MKP3  works as negative
modulator of the MAPK pathway by specifically dephos-
phorylating ERK1/2 [29,30]. At 2ss (HH7+), MKP3 was
faintly detected in the prospective hindbrain (Fig. 3i). At
HH8 and HH9, it was apparent in the ANR and main-
tained in the caudal hindbrain (Fig. 3j, o). The MKP3
expression domain was broader than the Fgf3-expressing
area (compare flat-mounts in Fig. 3g, o). MKP3 transcripts
were detected in the presumptive MHB territory at HH10
(Fig. 3l, p), where Fgf8 is expressed [31]. Transverse sec-
tions confirmed that MKP3 was indeed expressed in the
neural plate (Fig. 3m, arrowheads), and in the mesoderm
underlying the hindbrain (Fig. 3m, arrows), where Fgf3
and Fgf19 are known to be expressed (Fig. 3e; [32]). MKP3
expression was maintained in the hindbrain up to r3/r4
(Fig. 3l, p). MKP3 was expressed along the DV axis of the
neural tube (Fig. 3p), and it was downregulated in the
underlying mesoderm by HH10 (Fig. 3n). The ectoderm
Genes of the FGF synexpression group are expressed in the caudal hindbrain Figure 3
Genes of the FGF synexpression group are expressed in the caudal hindbrain. In situ hybridization of embryos 
between HH7+ and HH10 with: cFgf3 (a-h), cMKP3 (i-p), and cPea3 (q-x). Arrowheads in (e), (m) and (u) point to early expres-
sion in the neural plate. Pictures show whole-mount embryos (a-d, i-l,q-t), flat-mounted hindbrains (g, h,o,p,w,x) and transverse 
sections (e, f,m,n,u,v) whose correspondences to whole-mounts are specified in the pictures. cHB, caudal hindbrain; end, endo-
derm; mes, mesoderm; MHB, midbrain hindbrain boundary; op, otic placode; r, rhombomere; s, somite. Anterior is at the top.BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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corresponding to the otic placode was also positive for
MKP3 expression (Fig. 3n).
Pea3 (Polyoma enhancer activator 3)is a transcription factor
belonging to the Pea3 subfamily of the Ets transcription
factors. It is a common mediator of the FGF activity into
the nucleus and its expression is also regulated by FGF sig-
naling [33]. Pea3 was weakly detected in the prospective
hindbrain by 2ss (HH7+) (Fig. 3q). At HH8 and HH9,
Pea3 expression increased in the caudal hindbrain (Fig.
3r-s, w). Although at HH7+ Pea3  was very faintly
expressed in the neural plate and strongly in the meso-
derm (Fig. 3q, u), by HH10 Pea3 expression was mainly
confined to the hindbrain and the midbrain (Fig. 3t, x),
with no expression in the underlying mesoderm (Fig. 3v).
Note that contrary to MKP3, Pea3 was not expressed in the
otic ectoderm (Fig. 3v).
Sprouty2 (Spry2), as MKP3, is a negative modulator of the
MAPK pathway regulated by FGF signaling. It is known to
be expressed by HH10 in the MHB and r1 [34]. When the
expression of Sprouty2 was analyzed within the hindbrain,
two patches of Sprouty2 expression were observed. The
most anterior one corresponded to the MHB and rostral
hindbrain, whilst the most posterior patch, that was very
faint, was in a domain of the hindbrain not fully coinci-
dent with pERK1/2 activation or Fgf3 expression (data not
shown).
These results indicate that genes of the FGF synexpression
group are expressed in the caudal hindbrain. At early
stages of hindbrain patterning, HH7-HH9, MKP3  and
Pea3 coincided with Fgf3 expression in the hindbrain. By
HH10, MKP3 was still maintained in the hindbrain in an
area coincident with Fgf3 expression; on the other hand,
Pea3 was expanded in the hindbrain and in the midbrain.
SPRY2 expression in the caudal hindbrain was very tran-
sient and not fully coincident with the Fgf3.
MKP3 is a readout of FGF3 and vHnf1 functions in the 
hindbrain
We have shown that at HH7-HH9 stages MKP3 and Pea3
expression in the caudal hindbrain coincided with Fgf3
expression and ERK1/2 activation. In order to confirm
that these genes are indeed dependent on FGF signals
within the hindbrain we analyzed their expression after
blocking FGF signaling. As expected, when FGF signaling
was blocked in HH9 embryos by incubation with
medium containing 25 μM SU5402 during 2 h, both
MKP3  and  Pea3  expression were completely abolished
(Fig. 4a-d, n = 5/5 for MKP3 and n = 2/2 for Pea3). This is
in agreement with several studies that show that expres-
sion of both MKP3  and  Pea3  is FGF-dependent
[18,27,28,33,35-37].
Most of the reports suggested MKP3 as a readout of FGF8
activity. Since Fgf8 is not expressed in the caudal hind-
brain at this stage, we wanted to address whether Fgf3 was
sufficient to mediate MKP3 induction. For this purpose,
we overexpressed mFgf3  in the neural tube of HH8-9
embryos and analyzed cMKP3 expression. As early as 3 h
after electroporation the expression domain of MKP3 in
the hindbrain was expanded (Fig. 4e, n = 5/6) and by 6 h
after  mFgf3  electroporation,  MKP3  was ectopically
expressed in the entire hindbrain (Fig. 4f-g, n = 6/6). In
addition, mvHnf1 overexpression was also able to induce
MKP3 expression, although this effect was detected later,
only 8 h after electroporation (Fig. 4h, n = 8/8).
Pea3 and MKP3 expression are FGF-dependent Figure 4
Pea3 and MKP3 expression are FGF-dependent. 
Embryos were explanted and cultured during 2 h in control 
medium (a, c) or medium supplemented with 25 μM SU5402 
(b, d) and assayed for expression of cMKP3 or cPea3. 
Embryos were electroporated with mFgf3 (e-g) or mvHnf1 
(h), incubated during 3 h, 6 h or 8 h and then analyzed for 
cMKP3 (e-h) and for anti-GFP (g). Electroporated side is the 
right one. (g) Merge of MKP3 in situ hybridization and anti-
GFP staining to show the extension of the electroporation 
and the overlapping of GFP and ectopic MKP3. All the pic-
tures show whole-mount embryos with anterior to the top.BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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In summary, the expression of MKP3  and Pea3  in the
hindbrain relays on FGF signaling, and Fgf3  is able to
ectopically induce MKP3 in the neural tube as soon as 3 h
after overexpression. vHnf1  also induces MKP3  but
delayed with respect to Fgf3. This observation, together
with previous data that showed that vHnf1 activates Fgf3
(Fig. 1, [1]), suggests that MKP3  is induced by vHnf1
through Fgf3 and confirms that vHnf1 is upstream of FGF
signaling.
FGF activity in the hindbrain is mediated by the Ras-ERK1/
2 pathway
Next step was to dissect the FGF intracellular pathways
involved in hindbrain patterning. Different models are
proposed for the involvement of Ras-ERK1/2 and PI3K-
Akt pathways in patterning events. Most of them involve
uniquely the ERK1/2 pathway [16,27,38]. PI3K-Akt is
usually proposed to crosstalk with Ras-ERK1/2 in either
synergistic [39] or antagonistic manners [17,36]. To
understand the role of these pathways in the caudal hind-
brain we used a functional approach. ERK1/2 activity was
blocked with the chemical inhibitor PD184352 and PI3K
function with LY2944002 [28,40]. For general blockade
of FGF signaling, SU5402 was used [41].
We analyzed how inhibition of ERK1/2 and PI3K path-
ways affected the hindbrain expression of MKP3, the rea-
dout of FGF activity. Formate beads were soaked in the
specific inhibitors or in DMSO and then placed within the
caudal hindbrain of HH7+-HH8 explanted embryos.
Explants were incubated during 6 h at 38°C and then ana-
lyzed for MKP3 expression (Fig. 5A). When PD184252
coated beads were placed near the caudal hindbrain or the
presumptive isthmus/MHB of HH8 embryos, MKP3
expression was completely abolished in these territories
(Fig. 5Ac, n = 8/8). Conversely, MKP3  expression was
unaffected when LY294002 (Fig. 5Ad, n = 4/4) or DMSO
(Fig. 5Aa, n = 5/5) coated beads were implanted. These
results suggest that in the caudal hindbrain, as in the early
MHB, MKP3 is regulated by Ras-ERK1/2 but not by the
PI3K-Akt pathway. MKP3 plays a crucial role in control-
ling Ras-ERK1/2 cascade by specifically dephosphorylat-
ing ERK1/2. Our results support the view that in the
hindbrain MKP3 mediates a negative feedback in the Ras-
ERK1/2 pathway [27,28].
To confirm the non-regulation of MKP3 by the Akt path-
way in the hindbrain, we further validated the specificity
and the efficiency of the pathway-specific inhibitors
PD184352 and LY294002. For this purpose, we assayed
their function in Jurkat T cells sensitive to be activated by
both pathways [42-44]. Jurkat cells were treated and proc-
essed for protein extraction and western blot analysis was
performed to reveal total and phosphorylated forms of
Akt and ERK1/2. As expected, cells that were treated with
PD184352 gave negative signal for pERK1/2 but not for
pAkt. Conversely, cells that were treated with LY29402 did
not phosphorylate Akt but did ERK1/2 (Fig. 5B). In all
cases, total forms of ERK1/2 and Akt were detected (Fig.
5B). However, when Jurkat T cells were treated with
SU5402, pErk1/2 was downregulated but pAkt levels were
maintained (Fig. 5B). This is explained by the fact that Jur-
kat cells are PTEN mutants: PTEN is inactivated and as
consequence, PI3K action in the activation of Akt is rein-
forced [45]. This can be reverted by the application of
LY294002 which directly inhibits PI3K, but not by
SU5402 which is more upstream in the pathway, just at
the level of the RTKs (Receptor Tyrosin Kinases).
MKP3 is dependent on ERK1/2 but not Akt activation Figure 5
MKP3 is dependent on ERK1/2 but not Akt activation. 
(A) Beads soaked with specific inhibitors were placed in the 
caudal hindbrain or in the presumptive MHB of HH7+-8 
explanted embryos. Pharmacological treatments were as fol-
lows: DMSO (a), FGFR inhibitor SU5402 (b), ERK1/2 inhibi-
tor PD184352 (c), PI3K inhibitor LY294002 (d). Explants 
were incubated during 6 h at 38°C. (B) Jurkat cells (left side 
lanes) and HH7-8 explanted embryos (right side lanes) were 
treated with DMSO, SU5402, PD184352 or LY294002 and 
analyzed by western blot for total and phosphorylated forms 
of Akt and ERK1/2. PD184352 treatment impeded ERK1/2 
phosphorylation without affecting the PI3K-Akt pathway and, 
conversely, LY294002 treatment abolished Akt phosphoryla-
tion without affecting the Ras-ERK1/2 pathway. Embryos are 
shown in whole-mount with anterior to the top.BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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Next, we tested the inhibitors in embryonic explants.
HH7+-HH8 embryos were explanted and incubated dur-
ing 6 h at 38°C in the presence or absence of the inhibi-
tors. They were processed for protein extraction and
western blotted for phosphorylated and total forms of Akt
and ERK1/2. Treatment with 20 μM PD184352 was able
to specifically abolish ERK1/2 phosphorylation, while 40
μM LY294002 treatment abolished Akt phosphorylation
(Fig. 5B). When explanted embryos were treated with
SU5402, pAkt was downregulated but levels of pERK1/2
were maintained. This pERK1/2 maintenance was previ-
ously reported and attributed to a FGF-independent
wounding response induced when the embryo is
detached from the vitelline membrane during explanta-
tion [20,46]. These observations demonstrate that in the
hindbrain the expression of the MKP3 is dependent on the
Ras-ERK1/2 pathway, but independent of the PI3K-Akt
activity.
Finally, our goal was to know which intracellular FGF-
pathway was controlling hindbrain caudal identity. Loss-
of-function experiments showed that MafB  expression
was inhibited when the ERK1/2 pathway was blocked
with PD184352 (Fig. 6c, n = 8/8). Neither DMSO (Fig. 6a,
n = 8/8) nor LY294002 (Fig. 6d, n = 5/5) had this effect.
Similarly, beads coated with PD184352 suppressed
Krox20 expression in r5 (Fig. 6h, n = 6/6), while expres-
sion remained unaffected after treating with DMSO (Fig.
6f, n = 7/7) or LY294002 (Fig. 6i, n = 6/6). These results
indicate that FGF signaling mediates MafB  and  Krox20
expression through the Ras-ERK1/2 pathway with no
involvement of the PI3K-Akt pathway. As previously
shown with SU5402 in solution [1], beads coated with
SU5402 abolished MafB (Fig. 6b, n = 6/6) and Krox20
(Fig. 6g, n = 9/9) in the hindbrain region that was posed
in the vicinity to the bead implantation. Importantly,
these effects were only observed when embryos were
treated with SU5402 before the onset of these genes, 5ss
for MafB and 6ss for Krox20 in r5. Disruption of FGF sig-
naling had no effect on MafB or Krox20 expression after
this time window (Fig. 6e, j, n = 6/6 and n = 5/5 respec-
tively), although it still inhibited MKP3 expression (Fig. 5;
data not shown). These results suggest that FGF signaling
is involved in the induction of MafB and Krox20 in the
caudal hindbrain, but not in their maintenance. As
expected from our previous results showing that Fgf3 is
not dependent on FGF signaling [1], neither SU5402 (Fig.
6l, n = 5/5) nor PD184352 (Fig. 6m, n = 5/5) were able to
inhibit Fgf3 expression within the hindbrain at these early
stages.
Discussion
Previous results showed that ectopic vHnf1 induces expan-
sion of the Fgf3 expression domain within the hindbrain,
and activates Krox20 and MafB expression [1]. The current
work demonstrates that upregulation of Fgf3 upon vHnf1
overexpression is a rapid event suggesting that vHnf1
directly induces Fgf3 transcription. We also analyzed the
expression profile of the readouts of FGF activity in the
caudal hindbrain and show that they are induced by
vHnf1  overexpression, confirming the role of vHnf1
upstream FGF signaling. In addition, we have demon-
strated that FGF signaling in the hindbrain operates
through the Ras-ERK1/2 pathway activating Krox20 and
MafB , and FGF3 is the triggering factor.
Regulation of Fgf3 expression within the hindbrain
We have demonstrated that Fgf3 is rapidly induced upon
vHnf1 overexpression in the hindbrain. These results led
us to propose that Fgf3 induction is directly regulated by
vHnf1  in the caudal hindbrain. However, several other
players may be involved in regulating the expression of
Fgf3. This can be inferred from the complex and dynamic
expression profile that this gene displays within the hind-
brain. Indeed, we previously demonstrated that vHnf1 can
only induce Fgf3 in a discrete period of time that com-
prises the earliest steps of neurulation, from 0-1ss to 7ss
[1]. How Fgf3  expression is later controlled remains
largely unknown. Mutant mice for Kreisler  and  Hoxa1
exhibit reduction in the levels of Fgf3 expression in r5 and
r6, relating these genes to the regulation of Fgf3 [47-49].
In addition to this, a recent report proposes that Fgf3
expression in the chick hindbrain requires inhibition of
BMP signaling by follistatin and active FGF signaling [50].
However, in our hands, neither electroporation of mFgf3
nor loss-of-function of FGF by chemical inhibitors was
able to induce or abolish cFgf3  at short periods. Most
probably, this discrepancy is due to differences in the
length of treatment and the embryonic stage of the speci-
mens.
The fact that the Fgf3 expression profile within the hind-
brain is not exactly coincident in the different vertebrate
species [26,47,51,52] suggests that its regulation presents
substantial species-specific differences. Interestingly,
whereas we have demonstrated that in chick vHnf1 over-
expression rapidly induces cFgf3, the vhnf1 hypomorphic
mutant in zebrafish shows caudal expansion of fgf3 [12].
Detailed characterization of the Fgf3 regulatory regions in
different species would help to clarify this issue. To the
date, trials in this direction have failed to clearly localize
the regulatory region/s responsible for Fgf3 expression in
the hindbrain [25]. We have scanned the annotated chick
Fgf3 locus to identify potential vHNF1-binding sites in the
Fgf3 regulatory regions, but DNA sequence analysis did
not led us to identify any regulatory region of relevance.
BLAST analysis similarly failed to find conserved sequence
elements present amongst disparate genomes in the data-
bases. Therefore, identifying the potential vHNF1-binding
sites in this region represents a major goal in understand-BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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MafB and Krox20 are dependent on ERK1/2 but not on Akt activation Figure 6
MafB and Krox20 are dependent on ERK1/2 but not on Akt activation. HH7+-8 embryos (a-d, f-i,k-m) or HH9 (e, j) 
were explanted and beads soaked in specific inhibitors were placed in the caudal hindbrain. Afterwards, embryos were ana-
lyzed for Krox20, MafB or Fgf3 expression. Pharmacological treatments were as follows: DMSO (a, f,k), FGFR inhibitor SU5402 
(b, e,g,j,l), ERK1/2 inhibitor PD184352 (c, h,m), or PI3K inhibitor LY294002 (d, i), during 6 h. Embryos are shown in whole-
mount with anterior to the top.BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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ing the molecular mechanisms required for Fgf3 expres-
sion in the hindbrain.
A local gradient of ERK1/2 activity coincides with early 
expression of Fgf3 and FGF activity readouts in the caudal 
hindbrain
We studied FGF signaling during hindbrain patterning by
analyzing the profile of the FGF-activated Ras-ERK1/2
pathway. We show that the activated form of ERK1/2,
pERK1/2, is localized at early stages of development in
embryonic territories that are within or close to FGF
sources, such as: the forebrain influenced by FGF8/12/13
from the ANR [53], the midbrain and the hindbrain influ-
enced by FGF8 and FGF3 respectively, the precardiac mes-
oderm influenced by FGF8 from the endoderm [54] and
the otic placode under the influence of FGF3 from the
hindbrain and FGF19 from the mesoderm [32]. This is in
agreement with other works in mouse [55] and chick [20],
in which the localization of pERK1/2 is compared with
the expression profile of FGFRs1-4, MKP3 and the Pea3
subfamily of Ets factors during early embryonic develop-
ment. HH8 embryos display a pERK1/2 gradient extend-
ing anteriorly and posteriorly from the caudal hindbrain.
This gradient is consistent with the expression of Fgf3 in
this territory. At later stages, pERK1/2 is localized through-
out the hindbrain, being more intense in the MHB. There-
fore, our results suggest that the initial activation of
pERK1/2 in the caudal hindbrain depends on a local FGF
source within this area rather than being the tail of a gra-
dient established in more rostral areas. This idea is sup-
ported by our analysis of the FGF-activity readout MKP3.
MKP3 is expressed in two domains within the hindbrain,
a more rostral one in the MHB and a more posterior one
in the caudal hindbrain. Between these two domains there
is a region of the rostral hindbrain that does not express
MKP3, suggesting that this region has lower levels of
ERK1/2 activity. On the contrary, although Pea3 is also
initiated in two different domains, at later stages it is
expressed throughout the hindbrain. This could reflect
that  MKP3  and  Pea3  transcriptions require different
thresholds of ERK1/2 activity to be induced. We have ana-
lyzed the expression of Spry2 and FLRT3, two other genes
belonging to the FGF synexpression group. The negative
modulator Spry2 is highly expressed in the MHB and r1
but shows weak and very transient expression in the hind-
brain (data not shown). This expression does not fully
coincide with the expressions of Fgf3 or MKP3 in the cau-
dal hindbrain since it is slightly anterior to them. The pos-
itive modulator of FGF activity FLRT3 was observed in the
anterior part of the neural tube but not in the caudal hind-
brain (data not shown). This gene is later restricted to the
MHB [56]. Therefore, genes from the FGF synexpression
group are expressed in a dynamic and tissue-dependent
manner. Since the role of these genes is to regulate FGF
signaling (MKP3,  Spry2, FLRT3) or to modulate gene
expression in response to FGF signals (Pea3, Erm , Er81),
it is likely that regional and temporal variation in the lev-
els of expression of these genes during embryogenesis can
tune FGF signaling in each particular event. How this con-
text-specific tuning is achieved is largely unknown.
FGF activity in the caudal hindbrain is mediated by the 
Ras-ERK1/2 pathway with no involvement of the PI3K- Akt 
pathway
The Ras-ERK1/2 pathway is the most widely reported
pathway in FGF-required developmental processes
[16,18,27,37,38,57]. In certain cases PI3K-Akt pathway is
proposed to act together with the Ras-ERK1/2 pathway in
either synergistic or antagonistic manners [17,36,39]. We
show that activated effectors of both pathways are present
in protein extracts from hindbrains of HH8-9 embryos,
suggesting that both pathways are active in this tissue.
However loss-of-function studies of these pathways
showed that only the Ras-ERK1/2 pathway is involved in
the hindbrain patterning.
MKP3 has a very specific function in dephosphorylating
ERK1/2 and thus inactivating the Ras-ERK1/2 pathway.
Two models, one in the limb development and the other
in the isthmic organizer, propose MKP3 as a pivotal mol-
ecule in mediating crosstalk between PI3K-Akt and Ras-
ERK1/2 pathways [17,36]. Both models propose that
MKP3 is induced by the PI3K-Akt pathway to turn off the
Ras-ERK1/2. Our observations demonstrate that in the
hindbrain the expression of the MKP3 is dependent on the
Ras-ERK1/2 pathway but independent of the PI3K-Akt
pathway. Thus, in the caudal hindbrain, MKP3 would be
mainly involved in the autoregulation of the Ras-ERK1/2
pathway rather than in mediating crosstalk with the PI3K-
Akt pathway. This is in agreement with a model proposed
both in limb development and neural induction [27,28].
Recent work by Ekerot et al . strongly supports the hypoth-
esis that MKP3 is the mediator of an autoregulatory loop
within the Ras-ERK1/2 pathway [58]. This analysis shows
that the activation of the MKP3 promoter by FGF signal-
ing is ERK1/2-dependent and requires an intact Ets-bind-
ing.
MKP3 induction is detected as soon as 3 hours after Fgf3
overexpression and by 6 hours is expressed throughout
the hindbrain. MKP3 is also induced 8 hours after vHnf1
overexpression suggesting that this gene is regulated by
vHnf1  through FGF signaling. Conversely, MKP3  was
downregulated in the caudal hindbrain as soon as 2 hours
after blocking FGF signaling or the Ras-ERK1/2 pathway.
These timings are consistent with experiments in which
FGF-beads grafted in the chick epiblast induced MKP3
within 1 and 4 hours [27]. This induction was counter-
acted within 2 and 4 hours by adding a bead coated with
the FGFR inhibitor SU5402 or the ERK1/2 inhibitorBMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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PD184352 [28]. Therefore, this indicates that MKP3 is a
highly sensitive FGF readout that responds quickly to var-
iations in FGF signaling within the hindbrain. This quick
response could be important to differentiate between
punctual and sustained stimulation of the FGF-ERK1/2
pathway and, therefore, for modulating the different array
of responses that this pathway can promote.
The expression of the rhombomeric markers Krox20 and
MafB  is only dependent on the Ras-ERK1/2 pathway.
Thus, FGF signaling mediates caudal hindbrain patterning
through the Ras-ERK1/2 pathway. Previous findings in
zebrafish support this hypothesis: when vhnf1  is co-
expressed with a constitutively active form of ERK in the
zebrafish embryo the val/MafB  gene is ectopically
induced, just as occurs when co-expression of vhnf1 and
fgf3 is performed [12]. In addition, FGF blocking inhibits
Krox20 and MafB expression only if inhibitor treatment is
done before the onset of these genes, this is 5ss for MafB
and 7ss for Krox20. Thus, it seems that vHnf1 and FGF-
ERK1/2 signaling are needed for early establishment of
Krox20 and MafB expression rather that for their mainte-
nance. Consistently, certain evidences suggest that main-
tenance of Krox20  and  MafB  expression depends on
autoregulatory mechanisms [14,59,60]. Fig. 7 depicts data
obtained in several groups: the first hindbrain molecular
boundary is established in r4/r5 by mutual repression of
Irx and vHnf1 [61]; once vHnf1 is expressed in the caudal
hindbrain, it rapidly induces Fgf3 [1]. Finally, vHnf1 and
Fgf3 would cooperate via Ras-ERK1/2 to induce MafB and
Krox20 in the caudal hindbrain [12] and FGF signaling
would be regulated by MKP3.
Conclusion
In this report we show that MKP3 is the readout of FGF3
activity in the hindbrain, and Ras-ERK1/2 activity is nec-
essary for MKP3, Krox20 and MafB induction. Therefore,
these results suggest that the Ras-ERK1/2 pathway is
involved in mediating FGF signaling during caudal hind-
brain patterning with no apparent contribution of the
PI3K-Akt pathway. Taken together, the data presented in
this work and previous knowledge leads us to propose a
model in which vHnf1 is the molecular switch that initi-
ates the process of r5 and r6 specification. vHnf1 rapidly
induces Fgf3 in the caudal hindbrain, which activates the
Ras-ERK1/2 pathway. vHnf1 and Fgf3-ERK1/2 co-operate
for the induction of MafB expression in r5 and r6 at 4-5ss
and Krox20 in r5 at 6-7ss.
Model depicting the cooperation of vHnf1 and FGF signals in the induction of MafB and Krox20 in the caudal hindbrain Figure 7
Model depicting the cooperation of vHnf1 and FGF signals in the induction of MafB and Krox20 in the caudal 
hindbrain. (a) vHnf1 is very early expressed in the caudal neural plate with a sharp boundary laying in the prospective r4/r5 
boundary. This expression may be initiated very early in response to RA from the axial and paraxial mesoderm during mid/late 
stages of gastrulation [12,64,65]. Anterior limit of expression of vHnf1 may be established by mutual repression with an irx gene 
[61,65], probably irx3 (unpublished results).vHnf1 rapidly induces Fgf3 in the caudal hindbrain [1], which activates the Ras-
ERK1/2 pathway. vHnf1 and Fgf3-ERK1/2 co-operate for the induction of MafB expression in r5 and r6 at 4-5ss and Krox20 in 
r5 at 6-7ss. Krox20 induction is probably also dependent on MafB expression as suggested in mouse and zebrafish [8,11,66,67]. 
Krox20 is initially expressed in a narrow domain caudal to r4 and subsequently expands its expression area due to non-cell 
autonomous induction. Coinciding with the onset of Krox20 in r5, vHnf1 progressively regresses to r6 between 7 and 10ss. 
Mutual repression between vHnf1 and Krox20 may prevent expansion of Krox20 to r6. Anterior is to the left. (b) Putative regu-
lation of MafB and Krox20 expression by vHnf1 modulating FGF signaling through MKP3.BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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Methods
Embryos and staging
Chick embryos were obtained from fertilized hens' eggs
(Granja Gibert, Tarragona, Spain) and incubated in
humidified atmosphere at 38°C. Embryos were staged
according to Hamburger and Hamilton [62]. All proce-
dures used have been approved by the institutional ani-
mal care and use ethic committee (PRBB-IACUC), and
implemented according to national rules and European
regulations.
In ovo electroporation
mvHnf1-IRES-GFP , pCS2-mFgf3 and pCAβ-EGFP expres-
sion constructs, were overexpressed into the hindbrain of
HH7-9 chick embryos by in ovo electroporation. A solu-
tion containing the construct (2 μg/μl) was mixed 1:1
with Fast Green (1 μg/μl). By using a micropipette
(GC150-15 capillaries, Clark electromedical instruments,
pulled with a Narishige Japan puller), the plasmid solu-
tion was seeded on the top of the neural plate or microin-
jected in the lumen of the neural tube. A platinum
cathode was placed at the left side while the anode was
placed at the right side of the embryo. 4 square pulses (5,
10 or 20V) were generated by an electroporator Square
CUY-21 (BTX Co., Ltd, Tokiwasaiensu, Japan). M199
medium (Gibco) was added immediately after electropo-
ration to protect the embryo from dryness. Eggs were incu-
bated in humidified atmosphere at 38°C the desired time
period. After that, embryos were collected in cold Phos-
phate Buffered Saline (PBS pH7.4), selected for GFP fluo-
rescence under the microscope, and treated for RNA
extraction or fixed overnight in 4%paraformaldehyde
(PFA) in PBS for further analysis.
RNA extraction from fresh tissue
Electroporated chick hindbrains and mouse hepatic tissue
were isolated and placed in Trizol (Invitrogen). RNA was
isolated from Trizol using the chloroform extraction pro-
tocol provided by Invitrogen.
Semiquantitative RT-PCR
One-step PCR kit (Qiagen) was used to amplify specific
sequences of mvHnf1,  cFgf3  and  cGAPDH  . Primer
sequences were: 5' AGAGCTGCCCTGTACACTTG, 5' CAT-
GGTGACTGATTGTCGAA for mvHnf1;5' CCTTGGA-
GAAAAACAGCGTC and 5' AGCGTCCTCTCCTTCTCCTC
for cFgf3; 5' TACTGGAATGGCTTTCCGTGT and 5' ACTT-
TATTGATGTAAGGTGGTACAC for cGAPDH . The RT-PCR
program was the following: 30 min 50°C; 15 min 95°C;
1 min 94°C 1 min 58°C 1 min 72°C for 22, 25, 27 or 30
cycles; 10 min 72°C. 100 ng of total RNA was used per
sample. In each case, mvHnf1 and cFgf3 were amplified in
the same tube. A series of experiments were performed to
narrow down the number of amplification cycles needed
to visualize the genes of interest. Amplification products
were run in a 1.5% agarose gel. cGAPDH amplification
was used to normalize samples. The amplified bands were
quantified using the Quantity-one software (Biorad) and
the percentage of volume (%V) of each band was
obtained according to: [band V/total V] × 100. The vol-
ume of the band was measured as the sum of the intensi-
ties of all the pixels in a given area. Before calculating the
%V, the volumes were adjusted by subtracting the part
corresponding to the background. The relative level of
cFgf3 expression was estimated by calculating the ratio
between %V of the cFgf3 band and %V of the mvHnf1
band in each sample.
Treatment of Jurkat cells or whole embryos with specific 
inhibitors
Jurkat cells or whole embryos were used to assay the activ-
ity of FGF-signaling inhibitors. Cells were stimulated via
their TCR/CD3 complex to highly activate both the Ras-
MAPK and the PI3K FGF-dependent pathways [42-44].
105 cells per sample were incubated during 1 h with
DMSO, 25 μMSU5402 (Calbiochem), 40 μM LY294002
(Calbiochem) or 20 μM PD184352 (University of Dun-
dee) and processed for western blot.
Whole embryo organotypic explants and bead 
implantation
Collagen beds were prepared in 4-well dishes (Nunclon)
by adding a drop of 10 μl of Matrigel preparation (Invit-
rogen) in the center of each well. HH7-8 embryos were
collected and dissected in M199 medium. Organotypic
explants were prepared by cutting an area around the
embryo that comprised the entire area pellucida and part of
the area opaca . This kind of dissection ensures a good sur-
vival and development of the embryo and makes it easy to
attach to the Matrigel support. Explants were transferred
to the 4-well plates and positioned with the dorsal side to
the top and M199 was substituted by DMEM medium.
AGI-X2 formate beads (Bio-Rad) were coated with the fol-
lowing inhibitors: 5 mM SU5402, 20 mM LY294002 or 10
mM PD184352 [28] for 1-2 h at RT, protected from light
and washed in PBS before grafting. DMSO beads were
used as controls. Beads were grafted next to the hindbrain
region of the explanted embryos by using thin forceps.
Explants were incubated at 37.5°C in a water-saturated
atmosphere containing 5% CO2 during 2 h, 4 h, 6 h or 8
h. After that, explants were processed for western blot or
fixed overnight in 4%PFA/PBS for further analysis.
Whole mount in situ hybridization
Whole mount in situ hybridization was carried out using
digoxigenin-labeled riboprobes as previously described
[63]. Digoxigenin was detected with NBT/BCIP (Roche),
which provides a purple stain. Riboprobes were as fol-
lows: cFgf3 (dEST Data Bank), cKrox20 [59], cMafB [60],
cMKP3 [36], cPea3 [18] and cSpry2 [34].BMC Developmental Biology 2009, 9:61 http://www.biomedcentral.com/1471-213X/9/61
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Immunohistochemical detection of Green Fluorescent 
Protein (GFP) or phosphorilated ERK1/2
Embryos were collected in cold PBS and rapidly fixed with
4%PFA/PBS overnight at 4°C. They were washed with
PBS, dehydrated to 100% methanol, stored during 1 h at
-20°C and rehydrated to PBS. Afterwards, they were
treated with 6% H2O2/PBTx (PBS 1%triton) 2 h at rt,
washed in PBTx, incubated in blocking solution (PBTx
10% heat inactivated goat serum) for 1 h and subse-
quently incubated either with polyclonal antibody anti-
GFP [1:500] (Molecular Probes) overnight at 4°C [34], or
anti-dual phosphorylated (dp)ERK1/2 [1:50] (Cell Signal-
ing) during 5 days at 4°C. Donkey anti-rabbit conjugated
with horseradish peroxidase [1:200] (Amersham) was
used as secondary antibody for α-GFP experiments. In
anti-pERK stainings, biotinylated [1:50] (Vector) or
Alexa488 anti-rabbit antibodies (Molecular Probes) were
used. Embryos were subsequently washed with blocking
solution and incubated with the ABC kit (Vector) over-
night at 4°C. To develop the peroxidase activity a colori-
metric reaction was carried out with the AEC substrate
system (Lab Vision). Controls with no primary antibody
were performed in parallel to the experiment.
Western blots
Jurkat T cells (105cells/sample) or hindbrain tissue from
HH7+-HH9 chick embryos (pools of 10 embryos/sample)
were dissociated in 2 mM EDTA/PBS, homogenized in
10%SDS/Sample buffer and kept at -80°C. After 5 min at
100°C the lysates were run in a 12.5% polyacrilamide gel
and transferred to Immobilon-P PVDF membrane (Milli-
pore). Membranes were incubated with antibodies to
phosphorilated ERK1/2 [1:1000] (Cell Signaling), total
ERK1/2 [1:5000] (Promega), phosphorilated Akt [1:5000]
(Cell Signaling) and total Akt [1:5000] (Cell Signaling).
The secondary antibody was donkey anti-rabbit conju-
gated with HRP [1:2000] (Amersham). Chemilumines-
cence developing reagents were West Pico or West Femto
(Pierce Laboratories).
Photography and imaging
Whole, flat-mounted or sectioned embryos were photo-
graphed using Leica DMR fluorescence microscope or
Leica, MZ FL III fluorescence scope both with Leica DFC
300FX cameras. Images were captured with Leica IM50
v4.0 and analyzed with Adobe Photoshop v7.0.1.
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